Impact of pancreatic cold preservation on rat islet recovery and function

Transplantation

Volumn 87, Issue 10, 2009, Pages 1442-1450

  Pileggi, Antonello ^a   Ribeiro, Melina M ^a,b   Hogan, Anthony R ^a   Molano, R Damaris ^a   Cobianchi, Lorenzo ^a,c   Ichii, Hirohito ^a,d   Embury, Jennifer ^e   Inverardi, Luca ^a   Fornoni, Alessia ^a   Ricordi, Camillo ^a,d   Pastori, Ricardo L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b INSTITUTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^c UNIVERSITY OF PAVIA   (Italy)

^d JACKSON MEMORIAL HOSPITAL   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Athymic nude mice; Cold ischemia; Islet cell viability; Islet transplantation; Lewis rats; Pancreas preservation; Potency

Indexed keywords

ELONGATION FACTOR 1ALPHA; INTERLEUKIN 10; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; SERINE PROTEINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; UNIVERSITY OF WISCONSIN SOLUTION; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROTECTION; CELL STRESS; CELL SURVIVAL; CELL VIABILITY; CLADISTICS; CONTROLLED STUDY; CRYOPRESERVATION; DONOR SELECTION; ENZYME PHOSPHORYLATION; INFLAMMATION; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEOMICS; RAT;

ADENOSINE; ALLOPURINOL; ANIMALS; CELL SURVIVAL; COLD TEMPERATURE; CYTOKINES; GLUTATHIONE; GRAFT SURVIVAL; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, NUDE; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PANCREAS; PHOSPHORYLATION; PROTEIN KINASES; RAFFINOSE; RATS; RATS, INBRED LEW; TISSUE AND ORGAN HARVESTING;

EID: 67649576907     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a36b1e     Document Type: Article

References (71)

1. Pileggi A, Alejandro R, Ricordi C. Islet transplantation: Steady progress and current challenges. Curr Opin Organ Transplant 2006; 11: 7.
2. PonteGM,Pileggi A, Messinger S, et al. Toward maximizing the success rates of human islet isolation: Influence of donor and isolation factors. Cell Transplant 2007; 16: 595.
3. Lakey JR, Warnock GL, Rajotte RV, et al. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation1996; 61: 1047.
4. Noguchi H, Ueda M, Nakai Y, et al. Modified two-layer preservation method (M-Kyoto/PFC) improves islet yields in islet isolation. Am J Transplant 2006; 6: 496.
5. Nano R, Clissi B, Melzi R, et al. Islet isolation for allotransplantation: Variables associated with successful islet yield and graft function. Diabetologia2005; 48: 906.
6. Kin T, Senior P, O'Gorman D, et al. Risk factors for islet loss during culture prior to transplantation. Transpl Int 2008; 21: 1029.
7. Contreras JL, Eckstein C, Smyth CA, et al. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 2003; 52: 2935.
8. Kuroda Y, Kawamura T, Suzuki Y, et al. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation 1988; 46: 457.
9. Fraker C, Timmins MR, Guarino RD, et al. The use of the BD oxygen biosensor system to assess isolated human islets of langerhans: Oxygen consumption as a potential measure of islet potency. Cell Transplant2006; 15: 745.
10. Bottino R, Balamurugan AN, Bertera S, et al. Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes 2002; 51: 2561.
11. Abdelli S, Ansite J, Roduit R, et al. Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. Diabetes 2004; 53: 2815.
12. Bottino R, Balamurugan AN, Tse H, et al. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004; 53: 2559.
13. Abdelli S, Abderrahmani A, Hering BJ, et al. The c-Jun N-terminal kinase JNK participates in cytokine- and isolation stress-induced rat pancreatic islet apoptosis. Diabetologia 2007; 50: 1660.
14. Bottino R, Fernandez LA, Ricordi C, et al. Transplantation of allogeneic islets of Langerhans in the rat liver: Effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998; 47: 316.
15. Pileggi A, Molano RD, Ricordi C, et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 2006; 81: 1318.
16. Latif ZA, Noel J, Alejandro R. A simple method of staining fresh and cultured islets. Transplantation 1988; 45: 827.
17. Ricordi C, Gray DW, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990; 27: 185.
18. Ichii H, Inverardi L, Pileggi A, et al. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 2005; 5: 1635.
19. Cobianchi L, Fornoni A, Pileggi A, et al. Riboflavin inhibits IL-6 expression and p38 activation in islet cells. Cell Transplant 2008; 17: 559.
20. Pileggi A, Molano RD, Berney T, et al. Prolonged allogeneic islet graft survival by protoporphyrins. Cell Transplant 2005; 14: 85.
21. Berney T, Molano RD, Cattan P, et al. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 2001; 71: 125.
22. Pileggi A, Molano RD, Berney T, et al. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2001; 50: 1983.
23. Fornoni A, Cobianchi L, Sanabria NY, et al. The l-isoform but not d-isoforms of a JNK inhibitory peptide protects pancreatic beta-cells. Biochem Biophys Res Commun 2007; 354: 227.
24. Barbe-Tuana FM, Klein D, Ichii H, et al. CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets. Diabetes2006; 55: 2437.
25. Zhu S, Si ML, Wu H, et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282: 14328.
26. Matsumoto S, Rigley TH, Reems JA, et al. Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant 2003; 3: 53.
27. Matsumoto S, Qualley SA, Goel S, et al. Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation 2002; 74: 1414.
28. Rosenberg L, Wang R, Paraskevas S, et al. Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery1999; 126: 393.
29. Paraskevas S, Aikin R, Maysinger D, et al. Activation and expression of ERK, JNK, and p38 MAP-kinases in isolated islets of Langerhans: Implications for cultured islet survival. FEBS Lett 1999; 455: 203.
30. Eckhoff DE, Smyth CA, Eckstein C, et al. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction. Surgery 2003; 134: 169.
31. Fornoni A, Pileggi A, Molano RD, et al. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 2008; 51: 298.
32. Eckhoff DE, Eckstein C, Smyth CA, et al. Enhanced isolated pancreatic islet recovery and functionality in rats by 17beta-estradiol treatment of brain death donors. Surgery 2004; 136: 336.
33. Matsuda T, Omori K, Vuong T, et al. Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant 2005; 5: 484.
34. Noguchi H, Nakai Y, Matsumoto S, et al. Cell permeable peptide of JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function. Am J Transplant 2005; 5: 1848.
35. Noguchi H. Activation of c-Jun NH2-terminal kinase during islet isolation. Endocr J 2007; 54: 169.
36. Noguchi H, Nakai Y, Ueda M, et al. Activation of c-Jun NH2-terminal kinase (JNK) pathway during islet transplantation and prevention of islet graft loss by intraportal injection of JNK inhibitor. Diabetologia2007; 50: 612.
37. Ichii H, Sakuma Y, Pileggi A, et al. Shipment of human islets for transplantation. Am J Transplant 2007; 7: 1010.
38. Karpus WJ, Lukacs NW, McRae BL, et al. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 1995; 155: 5003.
39. Cameron MJ, Arreaza GA, Grattan M, et al. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J Immunol 2000; 165: 1102.
40. Solomon MF, Kuziel WA, Simeonovic CJ. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts. Cell Transplant 2004; 13: 503.
41. Wang HK, Park UJ, Kim SY, et al. Free radical production in CA1 neurons induces MIP-1alpha expression, microglia recruitment, and delayed neuronal death after transient forebrain ischemia. J Neurosci2008; 28: 1721.
42. Ma W, Wang ZR, Shi L, et al. Expression of macrophage inflammatory protein-1alpha in Kupffer cells following liver ischemia or reperfusion injury in rats. World J Gastroenterol 2006; 12: 3854.
43. Faleo G, Neto JS, Kohmoto J, et al. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 2008; 85: 1833.
44. Vasir B, Jonas JC, Steil GM, et al. Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets. Transplantation 2001; 71: 924.
45. Lai Y, Schneider D, Kidszun A, et al. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 2005; 79: 1530.
46. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 2001; 294: 564.
47. Yoshino Y, Aoyagi M, Tamaki M, et al. Activation of p38MAPKand/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells. Int J Oncol 2006; 29: 981.
48. Miura S, Matsuo Y, Saku K. Jun N-terminal kinase inhibitor blocks angiogenesis by blocking VEGF secretion and anMMPpathway. J Atheroscler Thromb 2008; 15: 69.
49. Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683.
50. Zhai Y, Shen XD, Gao F, et al. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology 2008; 47: 207.
51. Knoops L, Renauld JC. IL-9 and its receptor: From signal transduction to tumorigenesis. Growth Factors 2004; 22: 207.
52. Fontaine RH, Cases O, Lelievre V, et al. IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ 2008; 15: 1542.
53. Halloran PF, Homik J, Goes N, et al. The "injury response": A concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 1997; 29: 79.
54. McLaren AJ, Jassem W, Gray DW, et al. Delayed graft function: Risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant1999; 13: 266.
55. Nghiem DD, Cottington EM. Pancreatic flush injury in combined pancreas-liver recovery. Transpl Int 1992; 5: 19.
56. Busing M, Hopt UT, Quacken M, et al. Morphological studies of graft pancreatitis following pancreas transplantation. Br J Surg 1993; 80: 1170.
57. Busing M, Hopt UT, Schareck WD, et al. Ultrastructural changes of human pancreatic allografts after cold ischemia and reperfusion. Transplant Proc 1990; 22: 612.
58. Fe'taud V, Frossard JL, Farina A, et al. Proteomic profiling in an animal model of acute pancreatitis. Proteomics 2008; 8: 3621.
59. Yang M, Liu W, Wang CY, et al. Proteomic analysis of differential protein expression in early process of pancreatic regeneration in pancreatectomized rats. Acta Pharmacol Sin 2006; 27: 568.
60. Shen J, Person MD, Zhu J, et al. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 2004; 64: 9018.
61. Knudsen SM, Frydenberg J, Clark BF, et al. Tissue-dependent variation in the expression of elongation factor-1 alpha isoforms: Isolation and characterisation of a cDNA encoding a novel variant of human elongation-factor 1 alpha. Eur J Biochem 1993; 215: 549.
62. Bosutti A, Scaggiante B, Grassi G, et al. Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patients. Metabolism2007; 56: 1629.
63. Honore B, Baandrup U, Vorum H. Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues. Exp Cell Res 2004; 294: 199.
64. Makeyev AV, Liebhaber SA. The poly(C)-binding proteins: A multiplicity of functions and a search for mechanisms. RNA 2002; 8: 265.
65. Zhu Y, Sun Y, Mao XO, et al. Expression of poly(C)-binding proteins is differentially regulated by hypoxia and ischemia in cortical neurons. Neuroscience 2002; 110: 191.
66. Borgstrom A, Regner S. Active carboxypeptidase B is present in free form in serum from patients with acute pancreatitis. Pancreatology2005; 5: 530.
67. Fernstad R, Tyden G, Brattstrom C, et al. Pancreas-specific protein. New serum marker for graft rejection in pancreas-transplant recipients. Diabetes 1989; 38(suppl 1): 55.
68. Jonsson P, Kallen R, Montgomery A, et al. Protease activation in the porcine pancreatic allograft during preservation. Pancreas 1995; 11: 256.
69. Pak SC, Kumar V, Tsu C, et al. SRP-2 is a cross-class inhibitor that participates in postembryonic development of the nematode Caenorhabditis elegans: Initial characterization of the clade L serpins. J Biol Chem 2004; 279: 15448.
70. Silverman GA, Whisstock JC, Askew DJ, et al. Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell Mol Life Sci 2004; 61: 301.
71. Dickinson JL, Bates EJ, Ferrante A, et al. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem1995; 270: 27894.